{"id":180288,"date":"2026-08-27T07:29:00","date_gmt":"2026-08-27T05:29:00","guid":{"rendered":"https:\/\/renewable-carbon.eu\/news\/?p=180288"},"modified":"2026-08-21T12:01:40","modified_gmt":"2026-08-21T10:01:40","slug":"china-repurposing-pharma-mega-factories-to-make-novel-foods-gfi-report-reveals","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/china-repurposing-pharma-mega-factories-to-make-novel-foods-gfi-report-reveals\/","title":{"rendered":"China repurposing pharma mega-factories to make novel foods, GFI report reveals"},"content":{"rendered":"\n\n
\n
\"This
This mega-factory in Yichang, China, produces more than 11,000 tonnes of protein annually \u00a9 Angel Yeast<\/figcaption><\/figure><\/div>\n\n\n

China\u2019s industrial fermentation ecosystem is among the largest and most developed in the world. Decades of investment in fermentation-based pharmaceuticals and vitamins have created a manufacturing sector with vast production capacity, experienced technical talent, established supply chains, and competitive operating costs.<\/strong><\/p>\n\n\n\n

Historically, these companies have shown limited interest in food applications, since pharmaceuticals are often produced in smaller volumes and can command far higher prices.<\/p>\n\n\n\n

However, a new report<\/a> authored for GFI APAC by Australian biotech and geopolitics expert Dr. Dirk van der Kley<\/a> shows that due to the expansion of biopharmaceuticals capacity in China and increased competition from biosimilars (off-patent drugs that are broadly analogous to generics), the attractiveness of some pharmaceutical manufacturing markets has lessened.<\/p>\n\n\n\n

This has encouraged some major manufacturers to explore novel foods by leveraging their existing fermentation capacity to produce mycoprotein, yeast proteins, and precision-fermented fats\u2014particularly where applications may attract market premiums.<\/p>\n\n\n

\n
\"\"<\/a><\/figure><\/div>\n\n\n
<\/div>\n\n\n\n
Download the full report<\/span><\/a><\/div>\n\n\n\n

Government support for protein innovation as part of China\u2019s \u201cnew quality productive forces\u201d strategy is further encouraging diversification into the \u2018future food\u2019 sector\u2014creating an unprecedented opportunity for alternative-protein startups to drive down costs and rapidly ramp up their production capacity.<\/p>\n\n\n\n

International Startups Meet Chinese Scale-up<\/strong><\/h3>\n\n\n\n

Through his independent analysis and on-the-ground interviews in China, van der Kley\u2019s research uncovered many examples of Chinese fermentation manufacturers diversifying into alternative proteins:<\/p>\n\n\n

\n
\"\"
\u00a9 Nourish Ingredients<\/figcaption><\/figure><\/div>\n\n\n
<\/div>\n\n\n\n